sănătate
New blood test could help avoid more than 40% of prostate biopsies, study finds
A multi-center study that validates the clinical performance of IsoPSA – a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen (PSA) – will be presented during a special press conference at the 13th Annual Meeting of the Leggi tutto…